Search Results - Birgit Luber
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer by Jun Wang, Na Sun, Thomas Kunzke, Jian Shen, Annette Feuchtinger, Qian Wang, Raphael Meixner, Ronan Le Gleut, Ivonne Haffner, Birgit Luber, Florian Lordick, Axel Walch
Published 2024Artigo -
5
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) by Florian Lordick, Birgit Luber, Sylvie Lorenzen, S. Hegewisch-Becker, Gunnar Folprecht, Ewald Wöll, Thomas Decker, Esther Endlicher, Nadine Röthling, Tibor Schuster, Gisela Keller, Falko Fend, Christian Peschel
Published 2010Artigo -
6
Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations by Anja Bremm, Axel Walch, Margit Fuchs, Jörg Mages, Justus Duyster, Gisela Keller, Christine Hermannstädter, Karl‐Friedrich Becker, Sandra Rauser, Rupert Langer, Claus Hann von Weyhern, Heinz Höfler, Birgit Luber
Published 2008Artigo -
7
Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients by Jun Wang, Thomas Kunzke, Verena M. Prade, Jian Shen, Achim Buck, Annette Feuchtinger, Ivonne Haffner, Birgit Luber, Drolaiz H.W. Liu, Rupert Langer, Florian Lordick, Na Sun, Axel Walch
Published 2022Artigo -
8
Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistoc... by Armando Gamboa-Domı́nguez, Claudia Domínguez-Fonseca, Leticia Quintanilla‐Martinez, Edgardo Reyes-Gutiérrez, Dan Green, Arturo Angeles‐Angeles, Raymonde Busch, Christine Hermannstädter, Jörg Nährig, Karl‐Friedrich Becker, Ingrid Becker, Heinz Höfler, Falko Fend, Birgit Luber
Published 2004Artigo -
9
Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of... by Birgit Luber, Joëlle Deplazes, Gisela Keller, Axel Walch, Sandra Rauser, Martin Eichmann, Rupert Langer, Heinz Höfler, Susanna Hegewisch‐Becker, Gunnar Folprecht, Ewald Wöll, Thomas Decker, Esther Endlicher, Sylvie Lorenzen, Falko Fend, Christian Peschel, Florian Lordick
Published 2011Artigo -
10
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy by Niels Halama, Sara Michel, Matthias Kloor, Inka Zoernig, Axel Benner, Anna Spille, Thora Pommerencke, Doeberitz Magnus von Knebel, Gunnar Folprecht, Birgit Luber, Nadine Feyen, Uwe M. Martens, Philipp Beckhove, Sacha Gnjatic, Peter Schirmacher, Esther Herpel, Juergen Weitz, Niels Grabe, Dirk Jaeger
Published 2011Artigo -
11
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study by Ivonne Haffner, Katrin Schierle, Elba Raimúndez, Birgitta Geier, Dieter Maier, Jan Hasenauer, Birgit Luber, Axel Walch, Katharina Kolbe, Jorge Riera Knorrenschild, Albrecht Kretzschmar, Beate Rau, Ludwig Fischer von Weikersthal, Miriam Ahlborn, Gabriele Margareta Siegler, Stefan Fuxius, Thomas Decker, Christian Wittekind, Florian Lordick
Published 2021Artigo
Search Tools:
Related Subjects
Medicine
Cancer
Internal medicine
Oncology
Biology
Pathology
Cancer research
Epidermal growth factor receptor
Gene
Immunohistochemistry
Breast cancer
Cadherin
Cell
Colorectal cancer
Biochemistry
Cell biology
Cetuximab
Chemotherapy
Genetics
KRAS
Metastasis
Motility
Mutant
Mutation
Oxaliplatin
Prospective cohort study
Receptor
Signal transduction
Trastuzumab
Activator (genetics)